Programme Offered B.Sc. Bio Technology

B.Sc. Bio Technology
Dr. B.R. Ambedkar University, Agra
3 Years
10 + 2 with science

"Biotechnology can be defined in at least two ways. It can mean any technique which uses living organisms or parts of organisms to make or modify products, improve plant or animal productivity or to develop micro-organisms for specific use."


Biotechnology has tremendous potential in improving human and animal health, increasing agricultural productivity and providing a safe and clean environment. Biotechnology is a multi-disciplinary and rapidly advancing area and well-trained manpower is a pre-requisite for meaningful R&D and production in biotechnology.

Biotechnology is a frontier technology which has the potential to provide very substantial benefits to society in a wide range of sectors such as agriculture, medical and health, forestry, animal husbandry, environment protection, and improving the quality of products and services.
It has been said that the 21st century will belong to biotechnology.


Biotechnology, involving recombinant DNA, cell fusion and novel bio-process engineering techniques such as gene transfer, embryo-manipulation, monoclonal anti-bodies and so on. Biotechnology involves the integration of such disciplines as biology (plant, animal, microbial), biochemistry, molecular biology, genetics, chemical engineering and computer science.

Biotechnology has made profound impact in the fields of health, food, agriculture and environment protection. It has the potential to provide a wide array of benefits to humanity, including treatment for incurable diseases, safer, cheaper more effective drugs, more nutritional dairy and agriculture products, more resilient and productive crops and tree species, new sources of renewable energy and safer, more effective treatment of waste.

After years of painstaking research and development in biotechnology, the commercialization of this frontier technology for the betterment of mankind is poised to grow exponentially. With the help of biotechnology, new products and processes can be introduced to win a competitive edge over the traditional ones in terms of effectiveness, productivity, cost and safety.

For instance, diseases such as heart disease, cerebral vascular disease, emphysema, bronchitis, pneumonia, influenza, cancer, diabetes, AIDS, and liver diseases are, increasingly becoming leading causes of death in India. Genetics is involved in all of these. It would be of great interest to medical science to uncover the genetic roots of all these diseases, particularly since medical surveillance or life style changes could certainly reduce the risk considerably. It may be possible in future to take DNA from newborn babies and analyse 50 or more genes for allelic forms that can predispose the infants to many common diseases and provide therapeutic regimes that will circumvent the limitation of the defective genes.


Biotechnology can be a boon especially for India which has a large proportion of its population dependant on agriculture for their livelihood, very low per hectare yields, limited arable land for expansion of cultivation and increasing demand for food and fiber as a result of increasing population, and a desire for higher standards of living. Biotechnology can also help in arresting the rapid depletion of forest cover and in the treatment of waste.

Genetically engineered microbes are today widely used for producing drugs and vaccines in large scale at low costs that are of great importance (human, insulin, erythropoietin, and hepatitis-B vaccine). For example genetically engineered plants that make their own pesticides or are resistant to weedicides - are already in the market. Thus, over 60 percent of the acreage under soyabean in the United States have now genetically engineered soyabean that is resistant to the weedicides, Roundup. The total acreage under genetically engineered croup (for good or for bad) around the world exceeds 100 million acres today.

Genetically engineering plants are also poised to produce vaccines. A few hundred acres of genetically engineered banana plantation can provide enough vaccine to immunize 120 million children every year that need to be protected against four common diseases. One of the future sources of cheap protein-drugs in the coming years would be genetically engineered animals who would secrete these drugs in abundance (1-15 mg/ml) in their milk. They will be available at a cost of three or more times lower than the current cost


Biotechnology Market in India

The success of the Biotechnology industry has lead to sustained economic growth in the developed nations like US, European Countries & Canada. India is also fast emerging as a key player in biotechnology related activities & investments.

 

Biotechnology Industry Should Aim For $40 Billion in Revenues By 2015

Indian Biotechnology industry has been growing at a rate of 30%. Since 2003 -04. At this rate, the industry will easily achieve the $25 billion mark. India's biotech industry posted revenues of $1.5 billion in 2005 & is expected to top $2 billion in 2007. Growing at over 35% for the last five years, the industry would easily reach $20-25 billion, by 2010 predicted the biotech industry association. The industry will cross the $40 billion mark almost an eight fold jump by 2015.

US Pharmacopeia Opens Office In India
US Pharmacopeias the world's leading pharmaceuticals standards organization has ventured out of its Washington DC home for the first time in its 84 year history to set up an office & laboratories in the southern India city of Hyderabad on 9Feb, 2006.

Serum Institute to Invest Rs. 1,200 crore In India
India biotechnology today is making rapid strides in research & development. With the inauguration of the first biotech SEZ (Special Economic Zone) at Pune on 23Feb 2006, development of biotech industry in India will get the much needed encouragement & support.

Dr. Reddy's Lab Buys Germany's Betapharm for $570 Million
India's pharma major, Dr. Reddy's laboratories has announced a $ 570 million acquisition of betapharm , Germany's fourth largest generics company.

Reliance Life Science Invested In Biotechnology Area
Unlike other biotechnology companies , Reliance life Science (RLS) since its inception has been focusing on all areas of biotechnology like plant, medical, recombinant, clinical research, industrial biotech & bio-fuels.


View of Various Leaders & Organization About Biotechnology



Dr. Cyrus.s. Poonawalla
(Chairman & MD
Serum Institute of India Ltd.)

“Though our focus is on manufacturing vaccines for masses at an affordable price, we are forced to enter this new area. It will facilitate the growth of the biotech industry. Indian biotechnology today is making rapid strides in R&D”.


 

Kiran Mazoomdar
CMD, Biocon

” Says- R&D is seen as the next big opportunity for India. To establish India as a laboratory of the world fiscal policies need to support the high investment needs”.


 

Mukesh Ambani
Chairman, Reliance Group

"The rapid growth of biotechnology will also open up several avenues for creation of wealth. One indication of this is the estimate that the global biotechnology market will grow by about $100 billion in the next five years. Although this is small in comparison to the global GDP of $30 trillion, it signals that the race has started.



DG Shah
Secretary General
Indian Pharmaceutical Alliance (IPA)

“The Indian biotech sector is on the thres hold of significant growth opportunities. The biggest being an opportunity to create Indian as an R&D Hub for global biotech companies. The biotech industry had expected support from the budget on the recommendation to increase domestic & international investment”.


Kapil Sibbal
Union Minister for Science & Technology

India will beat the center stage of the biotech industry in the world. India's biotech industry posted revenues of $1.5 billion in 2005 & is expected to top $2 billion this year. I am very confident & comfortable with the $40 billion revenue by 2015”.


N. Chandrababu Naidu
Ex-Chief Minister of Andhra Pradesh

It is my belief the biotechnology can benefit, in several ways, all sections of the society but more so the very poor - for instance by increasing the availability and enhancing the nutritional value of food grains, by eliminating the use of harmful pesticides, by facilitating the manufacture of cheaper, safer and more effective drugs, by improving the quality of the livestock, by increasing the tree cover in the State and by treating waste material in a safe and eco-friendly manner.


Dr. APJ Kalam
President of India

President APJ Kalam has exhorted the industry and government to start a focused mission to capture at least five percent of %50 billion market share within 10 years. He suggested to launch vertical missions under an umbrella organisation like CII and NASSCOM in partnership with DST, R & D institutions, universities and public-private investment in at least 10 products in water, energy, agriculture, healthcare, space and defense and ICT sectors.



Vibrant Gujarat attract Rs 1,554 or Investment Commitment

Gujarat has attracted total investment commitment in biotechnology to the turn of Rs 1,554 Crores in biotechnology during “Vibrant Gujarat 2007”, a global invest or meet held on Jan-12-13, 2007 at Ahmedabad.

In this regard, 18 memorandum of understanding were signed in presence of Narendra Modi, C.M of Gujarat and Anandiben Patel minister of education government of Gujarat.

Major investment are form Akruti- Nirman- TCG Group for developing biotechnology park at Savli.



Acc. To sources, the state has attract around Rs.300 Crores investment in biotechnology HCL 2000 and another 200 Crores in last six years 2000-2006 the investment commitment to turn 1,554 Crores incoming five years. It shows Gujarat with its very strong pharma and health care agriculture, animal husbandry sector, offer ideal plate form for its growing economy. The Vast application of biotechnology in these sectors makes it an exciting area for business and investment .


Uttar Pradesh Biotech Policy

Uttar Pradesh to become more prosperous State through utilizing modern tools of biotechnology prosperity to farmers, generating employment in rural areas, food for all, top class health and environment.

Vision

Develop knowledge based economy, assure benefit of biotechnology to all section of the Students. Promote entrepreneurship in biotechnology based industries.

Mission

Uttar Pradesh However has been able to apply biotech for its development. In agriculture sector U.P made significant progress that is production of wheat (25.9 million ton, 35% of total production in country). Second in production of sugarcanes(122million ton,40%) fruit (8.5 million ton,18%).

Lucknow offer multidisciplinary facilities in area of biotechnology. About 3000 qualified scientist are working in four CSIR and other laboratories.


Development of biotech park for tissue culture and micro propagation. Biotech park has been developed as autonomous organization agriculture and provide able pilot facilities is promotion of biotech.

Lucknow has been declared as biotechnology city of India is 89 session of Indian science, congress at January 3, 2002.